ACell, Inc.
USPTO PatentsView assignee record - 22 granted patents across 9 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;).
The verdict
According to USPTO PatentsView, Acell ranks #13,278 of 49,997 tracked US assignees by granted-patent volume, with 22 patents across 9 technology areas.
- #13,278
- of 49,997 US assignees by volume
- 49th percentile
- by Innovation Score (34.9/100)
- 16.9
- avg claims per patent
- -71%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R13278 · US Corporation #13,278 · 22 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 22 grants
- MID-PACK #13,278/49,997
- PHOTO-FINISH 4C Medical
- CPC-NARROW A61L · 9 areas
- INNOV-THIN 34.9/100
- CLAIMS-RICH 16.9 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -71% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: 4C Medical Technologies, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Acell’s 34.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Acell
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- ACell · this assignee
ACell · this assignee
35 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Acell's Innovation Score is 34.9/100 (49th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Acell?
Each dot is one of Acell’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Acell’s own 16.9 claims/patent is at or below the 18.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Acell's grants concentrate
ACell, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 100% of grants classified under A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;). Peak complete grant year is 2016 (6 grants) versus a trough of 1 in 2018. By volume, Acell sits between 4C Medical Technologies, Inc. and Alcresta Therapeutics, Inc..
Acell's three-year grant acceleration
ACell, Inc. shows 2 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at ACell's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- 4C Medical
4C Medical Technologies, Inc.
22 patents
- Abberior Instrume…
Abberior Instruments GMBH
22 patents
- Academisch Medisc…
Academisch Medisch Centrum
22 patents
- Acsuper
Acsuper Technologies Inc.
22 patents
- ADC Therapeutics
ADC Therapeutics SA
22 patents
- Advanpack Solutio…
Advanpack Solutions PTE Ltd.
22 patents
- Albany Molecular…
Albany Molecular Research, Inc.
22 patents
- Alcresta Therapeu…
Alcresta Therapeutics, Inc.
22 patents
- Acell ◀
ACell, Inc.
22 patents
What this shows ACell holds 22 patents at rank #13,278, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near ACell
By rank, the assignees closest to #13,278 in granted patent volume.
- 4C Medical Technologies, Inc. #13,274 · 22 patents
- Abberior Instruments GMBH #13,275 · 22 patents
- Academisch Medisch Centrum #13,276 · 22 patents
- Acsuper Technologies Inc. #13,277 · 22 patents
- ADC Therapeutics SA #13,279 · 22 patents
- Advanpack Solutions PTE Ltd. #13,280 · 22 patents
- Albany Molecular Research, Inc. #13,281 · 22 patents
- Alcresta Therapeutics, Inc. #13,282 · 22 patents
Leaders in A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects…)
Other assignees with the most granted patents in ACell's primary technology class.
- The Procter & Gamble Company 378 in class
- Ethicon, Inc. 277 in class
- Abbott Cardiovascular Systems, Inc. 252 in class
- Boston Scientific Scimed, Inc. 240 in class
- Covidien LP 174 in class
- Warsaw Orthopedic, Inc. 167 in class
- DePuy Synthes Products, Inc. 161 in class
- W.L. Gore & Associates GmbH 146 in class
Acell's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
35 49th percentile higher than 49% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 5 | 22.7% |
| 2016 | 6 | 27.3% |
| 2017 | 4 | 18.2% |
| 2018 | 1 | 4.5% |
| 2019 | 1 | 4.5% |
| 2021 | 3 | 13.6% |
| 2023 | 1 | 4.5% |
| 2024 | 1 | 4.5% |
Which technologies does ACell, Inc. patent most?
Top 9 of 9 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
ACell, Inc.'s patent record in context - here's where to go next.
- ACell, Inc.'s lead technology class is A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;), 100% of its portfolio - see every assignee active in that class. Explore A61L
- Ranked #13,278 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare ACell, Inc. against 4C Medical Technologies, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 34.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.